Results 21 to 30 of about 2,899,588 (264)

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study [PDF]

, 2019
We carried out a retrospective observational study of 264 HER2-positive advanced breast cancer (ABC) patients to explore the efficacy of first-line treatment with pertuzumab/trastuzumab/taxane in real-world setting.
Corsi, Domenico, Barba, Maddalena, Giordano, Antonio, Sarmiento, R, Mariani, Luciano, Mazzotta, Marco, De Maria, Ruggero, Bria, E, Sperduti, I, Paris, I, Giotta, F, Botticelli, A, Magnolfi, E, Sanguineti, Giuseppe, Rossi, Ernesto, Giotta, Francesco, Ciliberto, G, Di Lauro, L, Latorre, Agnese, D’Onofrio, L, Fabbri, Maria Agnese, Tomao, S, Magnolfi, Emanuela, Magri, V, Garufi, C, Di Lauro, Luigi, Paris, Ida, Omarini, C, Ciliberto, Gennaro, Mazzotta, M, Latorre, A, Paoletti, G, Bria, Emilio, Graziano, Vincenzo, Veltri, Enzo, D'Onofrio, Loretta, Sergi, Domenico, Mirabelli, Rosanna, Mentuccia, L, Corsi, D, Foglietta, Jennifer, Giordano, Antonio|, Tonini, Giuseppe, Tomao, Silverio, Gelibter, Alain, Fabbri, MA, Barchiesi, Giacomo, Gelibter, A, Carbognin, L, Vici, P, Moscetti, L, Maugeri-Saccà, M, Sarmiento, Roberta, Barchiesi, G, Scinto, Angelo Fedele, Sperduti, Isabella, Graziano, V, Vici, Patrizia, Barni, Sandro, Pizzuti, Laura, Pizzuti, L, Moscetti, Luca, Corsi, Domenico Cristiano, Cassano, A, Magri, Valentina, Tonini, G, Sanguineti, G, Mirabelli, R, Marchetti, Paolo, Santini, D, Omarini, Claudia, Gamucci, T, Barni, S, Paoletti, Giancarlo, Foglietta, J, Gamucci, Teresa, Natoli, Clara, Garufi, Carlo, Giordano, A, Samaritani, Riccardo, Barba, M, Cassano, Alessandra, Iezzi, Laura, Maugeri-Saccà, Marcello, De Maria Marchiano, Ruggero, Santini, Daniele, Sergi, D, Mariani, L, Scinto, AF, De Maria, R, Veltri, E, Marchetti, P, Iezzi, L, Vaccaro, A, Vaccaro, Angela, Natoli, C, Rossi, E, Mentuccia, Lucia, Carbognin, Luisa, Samaritani, R, Botticelli, Andrea   +100 more
core   +1 more source

Perceptions of Endocrine Therapy in African-American Breast Cancer Survivors: Mixed Methods Study

JMIR Formative Research, 2021
BackgroundAlthough the incidence of breast cancer is lower in African-American women than in White women, African-American women have a decreased survival rate.
Donevant, Sara, Heiney, Sue P, Wineglass, Cassandra, Schooley, Benjamin, Singh, Akanksha, Sheng, Jingxi   +5 more
doaj   +1 more source

Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study

The Journal of Nutrition, Health and Aging
Objective: Serum 25-hydroxyvitamin D [25(OH)D] is known to be associated with depression. However, the evidence concerning the association between vitamin D status and depressive episodes in population with prediabetes and diabetes remains limited.
Huaxue Li, Guodong Liu, Yicheng Ma, Yingzhou Shi, Junming Han, Shengyu Tian, Hang Dong, Peipei Wang, Yingli Lu, Qiang Wang, Ling Gao, Yiping Cheng   +11 more
doaj   +1 more source

Association between Endocrine Therapy and Weight Gain after Breast Cancer Diagnosis among Japanese Patients: A Retrospective Cohort Study

Medical Sciences, 2021
Background: This study aimed to investigate the association between endocrine therapy and weight gain with a history of breast cancer. Methods: This was a retrospective cohort study.
Koki Okumatsu, Hideko Yamauchi, Rina Kotake, Masahiko Gosho, Yoshio Nakata   +4 more
doaj   +1 more source

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Current Oncology
Concerns exist regarding increased toxicities, including endocrine therapy toxicity, with concurrent radiation and endocrine therapy in early breast cancer (EBC).
Sharon F. McGee, Mark Clemons, Gregory Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L. Ng, Arif A. Awan, Sandeep Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque   +16 more
doaj   +1 more source

Executive Summary to EDC-2 : The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

, 2015
This Executive Summary to the Endocrine Society's second Scientific Statement on environmental endocrine-disrupting chemicals (EDCs) provides a synthesis of the key points of the complete statement.
Prins, Gail S.,, Gore, Andrea C.,, Chappell, Vesna A.,, Nadal, A.,, Toppari, Jorma,, Fenton, Suzanne E.,, Zoeller, R. Thomas,, Flaws, Jodi Anne,   +7 more
core   +1 more source

Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer [PDF]

, 2017
Objective: Although clinical trials recommend that women with hormone-dependent primary breast cancer remain on endocrine therapy for at least 5 years, up to 60% discontinue treatment early. We determined whether these women had consulted with clinicians
David Preen, Anna Kemp-Casey, Boyle, Frances, Christobel Saunders, Elizabeth Roughead, Frances Boyle, Kemp-Casey, Anna, Roughead, Elizabeth, Lopez, Derrick, Max Bulsara, Preen, David, Derrick Lopez, Bulsara, Max, Saunders, Christobel   +13 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs

iScience
Summary: Cancer prevention is a serious global challenge. We aimed to investigate the relationship between lipid-lowering drugs and cancers. We included participants based on the UK Biobank.
Zinuo Yuan, Chunhui Ding, Jingjing Duan, Ruonan Lian, Yingzhou Shi, Junming Han, Hang Dong, Yongfeng Song, Jiajun Zhao, Xiude Fan   +9 more
doaj   +1 more source

Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer

, 2020
Endocrine therapy is the gold-standard treatment for ER-positive/HER2-negative breast cancer. Although its clear benefit, patient compliance is poor (50–80%) due to its long administration period and adverse effects.
Li Yan, Masanori Oshi, Kazuaki Takabe, Yoshihisa Tokumaru, Fernando A. Angarita, Itaru Endo, Ryusei Matsuyama   +6 more
core   +1 more source